Skip to content
healthcare.dev

CINQAIR

NDC 59310-610, Reslizumab, injection, solution, concentrate, from Teva Respiratory, LLC.

Product NDC
59310-610
Status
Listed
Labeler
Teva Respiratory, LLC
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761033
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59310-610 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RESLIZUMAB10 mg/mL

Pharmacologic classes

Interleukin-5 Antagonist [EPC]; Interleukin-5 Antagonists [MoA]

Package NDCNDC-11Package
59310-610-31593100610311 VIAL, SINGLE-USE in 1 CARTON (59310-610-31) / 10 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/053b9158-2a5b-48b9-bf47-5fa78a35ec33
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=59310-610

Use it

Look up 59310-610 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59310-610 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59310-610. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.